Maher Awad
Psychiatry · Aberdeen, NJNPI 1134106677
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 409 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 45.7% of the total. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 409 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Sunovion Pharmaceuticals Inc.$909
- Johnson & Johnson$499
- Alkermes, Inc.$463
- Otsuka America Pharmaceutical, Inc.$359
- plus $777 from 9 others
What the payments were for
- Food & beverage$9,235100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 279 | $4,228 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $2,009 |
| Sunovion Pharmaceuticals Inc. | 32 | $909 |
| Johnson & Johnson | 20 | $499 |
| Alkermes, Inc. | 10 | $463 |
| Otsuka America Pharmaceutical, Inc. | 8 | $359 |
| Teva Pharmaceuticals USA, Inc. | 10 | $311 |
| Sanofi | 1 | $123 |
| Avanir Pharmaceuticals, Inc. | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Lundbeck LLC | 4 | $56 |
| Indivior Inc. | 3 | $50 |
| Shire North American Group Inc | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$1,466
- VRAYLAR$1,188
- ARISTADA$852
- LATUDA$349
- INVEGA SUSTENNA$254
- ARISTADA INITIO$213
- KEVZARA$123
- UZEDY$120
- ABILIFY MAINTENA$120
- ABILIFY ASIMTUFII$120
- REXULTI$112
- NUEDEXTA$107
How this compares
$9,244 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Varenicline Tartrate | 12 | $2,540 |
| Buprenorphine Hcl | 52 | $1,706 |
| Clozapine | 12 | $1,063 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $854 |
| Duloxetine Hcl | 62 | $674 |
| Bupropion XlBupropion Hcl | 53 | $672 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $291 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $290 |
| Alprazolam | 56 | $281 |
| Sertraline Hcl | 46 | $269 |
| Escitalopram Oxalate | 33 | $255 |
| Clonazepam | 70 | $244 |
| Fluoxetine Hcl | 11 | $241 |
| Gabapentin | 26 | $198 |
| Trazodone Hcl | 49 | $178 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Aberdeen
- Sahar AwadAberdeen$11K
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
- Boris BorodulinEast Brunswick$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.